E
Keros Therapeutics, Inc. KROS
$11.58 $0.110.96%
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

12/31/2024 09/30/2024 06/30/2024 03/31/2024 12/31/2023
Revenue 3.55M 651.00K 271.00K 234.00K 151.00K
Total Other Revenue -- -- -- -- --
Total Revenue 3.55M 651.00K 271.00K 234.00K 151.00K
Cost of Revenue 18.29M 44.32M 29.23M 21.25M 14.08M
Gross Profit -14.74M -43.66M -28.96M -21.02M -13.93M
SG&A Expenses 40.75M 39.19M 38.52M 37.36M 34.83M
Depreciation & Amortization -- -- -- -- --
Other Operating Expenses -- -- -- -- --
Total Operating Expenses 214.38M 204.69M 188.93M 179.79M 170.09M
Operating Income -210.83M -204.03M -188.66M -179.56M -169.94M
Income Before Tax -187.05M -181.57M -168.05M -160.30M -152.99M
Income Tax Expenses 300.00K -- -- -- --
Earnings from Continuing Operations -187.35 -181.57 -168.05 -160.30 -152.99
Earnings from Discontinued Operations -- -- -- -- --
Extraordinary Item & Accounting Change -- -- -- -- --
Minority Interest in Earnings -- -- -- -- --
Net Income -187.35M -181.57M -168.05M -160.30M -152.99M
EBIT -210.83M -204.03M -188.66M -179.56M -169.94M
EBITDA -209.60M -202.89M -187.62M -178.63M -169.13M
EPS Basic -5.01 -5.21 -5.13 -5.14 -5.19
Normalized Basic EPS -3.13 -3.25 -3.20 -3.21 -3.25
EPS Diluted -6.42 -6.62 -6.46 -6.47 -6.52
Normalized Diluted EPS -3.13 -3.25 -3.20 -3.21 -3.25
Average Basic Shares Outstanding 149.72M 139.51M 131.58M 125.08M 117.77M
Average Diluted Shares Outstanding 149.72M 139.51M 131.58M 125.08M 117.77M
Dividend Per Share -- -- -- -- --
Payout Ratio -- -- -- -- --
Weiss Ratings